Verition Fund Management
TAK icon

Verition Fund Management’s Takeda Pharmaceutical TAK Stock Holding History

Verition Fund Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-397,464
Closed -$6.14M – 3992
2025
Q2 		$6.14M Sell
397,464
-442,855
-53% -$6.54M 0.03% 916
2025
Q1 		$12.5M Buy
+840,319
New +$11.8M 0.06% 379
2024
Q4 		– Sell
-107,808
Closed -$1.53M – 3514
2024
Q3 		$1.53M Buy
+107,808
New +$1.53M 0.01% 1592
2022
Q3 		– Sell
-14,210
Closed -$200K – 3203
2022
Q2 		$200K Buy
+14,210
New +$203K ﹤0.01% 1953
2022
Q1 		– Sell
-17,034
Closed -$232K – 3020
2021
Q4 		$232K Buy
+17,034
New +$239K ﹤0.01% 2152

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Verition Fund Management's TAK Position: Q3 2025 in Review

Verition Fund Management sold out of Takeda Pharmaceutical (TAK) in Q3 2025, closing a stake of 397,464 shares — an estimated $6.14M sold.

Verition Fund Management first reported a position in TAK in Q4 2021 and held it in 5 quarters. The position peaked at $12.5M in Q1 2025. 329 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

  • Verition Fund Management reported no remaining Takeda Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 397,464 Takeda Pharmaceutical shares in Q3 2025, an estimated $6.14M.
  • Verition Fund Management first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 5 quarters.
  • Verition Fund Management's Takeda Pharmaceutical position peaked at $12.5M in Q1 2025.
  • 329 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.